A multicenter study of trimodality therapy for patients 75 years and older with esophageal cancer.

Authors

null

Niamh Anna McDonnell

Mayo Clinic, Rochester, MN

Niamh Anna McDonnell , Scott Lester , Michael G. Haddock , Thorvardur Ragnar Halfdanarson , Amit Mahipal , Grant M. Spears , Zhongxing X. Liao , Shanda H Blackmon , Christopher Leigh Hallemeier , Steven H. Lin , Kenneth Merrell

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach

Track

Cancers of the Esophagus and Stomach

Sub Track

Multidisciplinary Treatment

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr 131)

DOI

10.1200/JCO.2019.37.4_suppl.131

Abstract #

131

Poster Bd #

L3

Abstract Disclosures

Similar Posters

First Author: Go Ikeda

First Author: Go Ikeda

Poster

2015 Gastrointestinal Cancers Symposium

Risks of severe adverse events of docetaxel, cisplatin, and 5-fluorouracil (DCF) combination chemotherapy of esophageal cancer.

Risks of severe adverse events of docetaxel, cisplatin, and 5-fluorouracil (DCF) combination chemotherapy of esophageal cancer.

First Author: Sayako Yuda